| Print
Gossamer Bio (GOSS)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
Address
Forecast key dates
| Name | Key Date |
|---|---|
| Gossamer Bio Inc Fourth Quarter Earnings Results for 2026 | 2027-03-17T00:00:00 |
| Gossamer Bio Inc Annual Report for 2026 | 2027-03-17T00:00:00 |
| Gossamer Bio Inc Third Quarter Earnings Results for 2026 | 2026-11-05T00:00:00 |
| Gossamer Bio Inc Second Quarter Earnings Results for 2026 | 2026-08-05T00:00:00 |
| Gossamer Bio Inc Annual General Meeting for 2026 | 2026-06-25T09:00:00 |
| Gossamer Bio Inc First Quarter Earnings Conference Call for 2026 | 2026-05-15T16:30:00 |
| Gossamer Bio Inc First Quarter Earnings Results for 2026 | 2026-05-15T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Gossamer Bio Inc Annual Report for 2025 | 2026-03-17T00:00:00 |
| Gossamer Bio Inc Fourth Quarter Earnings Results for 2025 | 2026-03-17T00:00:00 |
| Gossamer Bio Inc Third Quarter Earnings Results for 2025 | 2025-11-05T00:00:00 |
| Cantor Global Healthcare Conference | 2025-09-03T09:10:00 |
| Gossamer Bio Inc Second Quarter Earnings Results for 2025 | 2025-08-05T00:00:00 |
| Gossamer Bio Inc Annual General Meeting for 2025 | 2025-06-25T09:00:00 |
| Gossamer Bio Inc First Quarter Earnings Conference Call for 2025 | 2025-05-15T16:30:00 |
| Gossamer Bio Inc First Quarter Earnings Result for 2025 | 2025-05-15T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2026 AJ Bell. All rights reserved.